Telix (TLX.AX) traded down -3.44 % during a 24 hours period ending at 05:14 PM Central Europe on Monday 26th. One Telix stock can currently be bought for about AUD 12.85 on popular exchanges. Current supply of Telix stocks is 338.8 mn. Telix has a current market capitalization of AUD 4.4 bn and approximately AUD 41.6 mn worth of Telix was traded on exchanges in the last 24 hours. Since last month end, Telix has traded -16.2 % down. Simple moving average of last 200 days is at AUD 13.99. The highest price of past 52 weeks was recorded at AUD 18.22 on 09/15/2026. 52 weeks low was at AUD 8.26 on 02/17/2026.

Summary of the latest news for Telix

Telix Pharmaceuticals Limited reported a change in director interests on 22 October 2026. William R Jellison and Joanne S Jellison jointly acquired 25 000 American Depositary Shares, each representing an ordinary share, while retaining their existing 21 597 Share Appreciation Rights. The transaction was executed through an on‑market trade on Nasdaq. No other contracts or securities were reported as affected, and the trade did not occur during a closed period requiring prior clearance.

Here is how related stocks have performed in the past 24 hours:

  • Harvey Norman (HVN.AX) traded up 3.22 % and now trades at AUD 4.15. Harvey Norman has a market capitalisation of AUD 5.2 bn. Harvey Norman has a current price to earnings ratio of 9.75.

  • Ventia Services Pty Lt (VNT.AX) traded down -0.67 % and now trades at AUD 5.79. Current market capitalisation for Ventia Services Pty Lt is AUD 4.8 bn. Ventia Services Pty Lt has a current price to earnings ratio of 18.36.

  • New Hope (NHC.AX) traded up 2.52 % and now trades at AUD 6.07. New Hope has a market capitalisation of AUD 5.1 bn. New Hope has a current price to earnings ratio of 31.68.

  • Seek (SEK.AX) traded up 0.96 % and now trades at AUD 13.51. Current market capitalisation for Seek is AUD 4.9 bn.

  • Treasury Wine Estates (TWE.AX) traded down -0.17 % and now trades at AUD 5.82. Treasury Wine Estates has a market capitalisation of AUD 4.7 bn. Treasury Wine Estates remains one of the most closely watched names on the Australian market. In recent trading, the stock has attracted a modest amount of short interest, reflecting cautious sentiment from some investors. Despite this, the company has not seen a sharp decline in its share price, and short positions have been relatively stable over the past week. Treasury Wine Estates is also mentioned among other well‑covered stocks, indicating that it continues to attract attention from a broad range of market participants. The overall trend suggests that while there is some speculative activity, the company’s equity is still regarded as a solid part of the broader market portfolio.

About Telix

Telix Pharmaceuticals Ltd. is a biotechnology company based in North Melbourne, Australia. The company specializes in developing and commercializing molecularly-targeted radiation therapy for the treatment of prostate, renal, and brain cancer globally.